Objective To examine the expression levels of P16 in the patients with chronic myelogenous leukemia ( CML), and evaluate the pathogenesis and clinical significance of P16 in CML. 目的检测细胞周期调控因子P16在慢性粒细胞性白血病(CML)患者中的表达,探讨P16在CML中的作用机制及临床意义。
Systemic review on progress of drug therapy for chronic myelogenous leukemia 慢性髓细胞白血病化疗的回顾及进展
Priming Regimen for Patients with Refractory or Relapsed Acute Myelogenous Leukemia ( in Vivo and in Vitro); 预激方案治疗急性难治性、复发性髓性白血病的初步研究(体内、体外)
Objective To carry out health education of patients with chronic myelogenous leukemia to improve patients self-conservancy and life quality. 目的对慢性粒细胞白血病患者进行健康教育,提高患者的自我保健能力和生活质量。
We conducted a trial to analyze the efficacy and safety of voriconazole in the prevention of lung infiltrates during induction chemotherapy for acute myelogenous leukaemia ( AML). 我们进行了一项临床试验旨在分析伏立康唑在急性髓细胞白血病化疗诱导阶段预防肺部浸润的有效性和安全性。
Expression and regulation of Bim protein in chronic myelogenous leukemia 慢性粒细胞性白血病中Bim蛋白表达及调控研究
The drug blocks a mutant protein that causes chronic myelogenous leukemia ( CML), becoming the first chemotherapy to specifically target cancer cells. 该药可以阻断引起慢性髓细胞性白血病(CML)的突变蛋白,成为第一个特异靶向癌细胞的化学药。
Nosocomial Infection in Senile Patients with Acute Myelogenous Leukemia after Chemotherapy: Risk Factors and Clinical Analysis 老年急性髓系白血病化疗后医院感染的危险因素及临床分析
Screening Experimental Studies of DNA Electrochemical Probes for Detection of Relative Genes in Chronic Myelogenous Leukemia 检测慢性粒细胞白血病相关基因的DNA电化学探针筛选实验研究
Application of BCR-ABL in chronic myelogenous leukemia BCR-ABL探针在慢性粒细胞白血病中的应用
Compared with acute myelogenous leukemia, patients with acute lymphoblastic leukemia had more poor cellular immune function. 与急性髓细胞性白血病相比,急性淋巴细胞性白血病细胞免疫功能更为低下。
Effect of FLAG Consolidation Therapy on Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Acute Myelogenous Leukemia FLAG巩固治疗急性髓系白血病对自体外周血造血干细胞动员的影响
Drugs that target a single switch have transformed the treatment of some patients with certain cancers& for instance, Gleevec and chronic myelogenous leukemia. 以单一的调空点为靶点的药物已经转变为某些肿瘤患者的治疗方法。比如,格列卫和慢性骨髓性白血病。
The pathological changes and clinical features of acute myelogenous leukemia and chronic myelogenous leukemia. 急性髓性白血病及慢性髓性白血病的病理改变及临床表现(七年制学生自学)。
The Investigation of the Expression and the Function of SHIP Gene in the Chronic Myelogenous Leukemia SHIP基因在慢性粒细胞白血病发病中的作用及机制探讨
Chromosome karyotype analysis and its clinical significance in chronic myelogenous leukemia 慢性粒细胞白血病染色体核型分析及其临床意义
A Systematic Review of MA versus DA Regimen for Patients with Acute Myelogenous Leukemia MA与DA方案初治急性髓系白血病的系统评价
Clinical and experimental studies on chronic myelogenous leukemia ( report of 60 cases) 慢性粒细胞白血病临床和实验研究(附60例报告)
The Significance of Y Chromosome Loss and Other Chromosome Aberration in Acute Myelogenous Leukemia Y染色体丢失与其它染色体畸变在急性髓性白血病中的意义
Conclusion The combination therapy with interferon alpha and hydroxyurea for chronic myelogenous leukemia is relatively safe and effective. 结论INF合并羟基脲治疗慢性粒细胞性白血病,CR率高,可以减少Ph1阳性克隆细胞,是一种较为安全有效的治疗方法。
Objective To study the effects of matrine associated with chemotherapy on acute myelogenous leukemia ( AML). 目的研究迈清注射液联合化疗治疗急性髓细胞性白血病(AML)。
Objective: To investigate the clinical characteristics, treatment responsiveness and prognostic factors of childhood acute myelogenous leukemia. 目的:了解儿童急性髓系白血病的临床特点、治疗疗效及预后因素。
Multiple samples were collected during LVL from 21 patients with acute myelogenous leukemia or multiple myeloma. 21例MM或AML患者接受了采集中取样的LVL相关研究;
Objective: To study the level of bcr/ abl fusion gene expression in the diagnosis, treatment and prognosis in chronic myelogenous leukemia ( CML) and primary myelofibrosis ( MF). 目的探讨bcr/abl融合基因的表达水平在慢性粒细胞白血病(CML)和原发性骨髓纤维化(MF)患者的诊断、疗效及预后观察中的意义。
Objective: To investigate the clinical significance of the expression of p-glycoprotein ( p-gp) and Bcl-2 protein in acute leukemia ( AL) and chronic myelogenous leukemia ( CML). 目的:探讨P-gp和Bcl-2蛋白与急性白血病(AL)临床耐药和慢性粒细胞性白血病(CML)病情进展的关系。